文献速递类风湿关节炎

类风湿关节炎疾病影响评分(RAID)在疾病活动度复发中的表现

Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity.
PubMed 文献 · RMD Open · 2024-01-12

在ARCTIC REWIND项目中,248例持续缓解的类风湿关节炎患者被随机分配继续稳定治疗或减量,共发生56次复发。复发时RAID总分及各成分、患者总体评估、DAS和CRP均显著变化;RAID区分复发的AUC为0.88,优于CRP(0.76),但低于患者总体评估(0.92)和DAS(0.94)。

要点

  • RAID在复发访视时较前一次访视显著升高,支持其响应复发的能力。
  • RAID区分复发的AUC为0.88,显著优于CRP的0.76。
  • RAID区分复发的准确性低于患者总体评估(AUC 0.92)和DAS(AUC 0.94)。

核心结论

  • 疾病活动度复发与RAID中位数显著升高相关,支持RAID响应复发的能力。

研究设计与样本

  • ARCTIC REWIND项目将持续缓解的类风湿关节炎患者随机分配至继续稳定治疗组或减量组。
  • 分析纳入248例患者,共发生56次复发,复发定义为DAS>1.6且DAS升高≥0.6且44个检查关节中≥2个肿胀,或患者与风湿科医生一致认为发生临床显著复发。

主要发现

  • 复发相关访视时RAID、患者总体评估、DAS和CRP均显著变化(p<0.001)。
  • RAID区分复发的AUC为0.88(95%CI 0.83至0.93),显著优于CRP的0.76(95%CI 0.69至0.84)。
  • RAID区分复发的准确性低于患者总体评估的0.92(95%CI 0.87至0.97)和DAS的0.94(95%CI 0.90至0.98)。
  • RAID各成分中区分复发准确性最高为疼痛(AUC 0.91,95%CI 0.86至0.95),最低为睡眠(AUC 0.69,95%CI 0.59至0.79)。

关键数值与推荐

  • 复发定义:DAS>1.6、DAS升高≥0.6且44个检查关节中≥2个肿胀,或患者与风湿科医生一致认为发生临床显著复发。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To explore the performance of the EULAR-initiated patient-reported Rheumatoid Arthritis Impact of Disease (RAID) questionnaire in relation to flares in disease activity, including comparison with other disease activity outcomes. METHODS: Patients with rheumatoid arthritis in sustained remission were randomised to continued stable treatment or tapering in the ARCTIC REWIND project. In patients with flares within 12 months, we compared RAID (total score and components) at the flare visit with the visit prior to and the visit following flare, using Wilcoxon signed-rank test. Similar analyses were performed for patient global assessment, Disease Activity Score (DAS) and C reactive protein (CRP). The discriminative accuracies of RAID, patient global assessment, DAS and CRP with respect to disease activity flares were assessed by receiver operating characteristic (ROC) analyses based on logistic regression models. Flare was defined as a combination of DAS >1.6, a DAS increase ≥0.6 and ≥two swollen joints (of 44 examined) or could be recorded if patient and rheumatologist agreed that a clinically significant flare had occurred. RESULTS: In total, 248 patients were included in the analyses, with 56 flares. RAID, patient global assessment, DAS and CRP all changed significantly at the visits related to flare (p<0.001). Area under the curve (95% CI) values indicated that RAID (0.88 (0.83 to 0.93)) was significantly more accurate than CRP (0.76 (0.69 to 0.84)) in discriminating flare, and less accurate than patient global assessment (0.92 (0.87 to 0.97)) and DAS (0.94 (0.90 to 0.98)). The RAID components with highest and lowest discriminative accuracies were pain (0.91 (0.86 to 0.95)) and sleep (0.69 (0.59 to 0.79)). CONCLUSION: Disease activity flares were associated with a significant increase in median RAID, supporting its ability to respond to flare. TRIAL REGISTRATION NUMBER: NCT01881308.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Holten K, Paulshus Sundlisæter N, Sexton J, et al. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity. RMD Open. 2024. PMID: 38216290. doi:10.1136/rmdopen-2023-003486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。